Gilead Q1 2024 Earnings. Gilead sciences (gild 0.80%) q1 2024 earnings call apr 25, 2024, 4:30 p.m. Total first quarter 2024 revenue increased 5% to $6.7 billion, compared to the same period in 2023, primarily due to higher hiv, oncology and liver disease sales.
Total first quarter 2024 revenue increased 5% to $6.7 billion, compared to the same period in 2023, primarily due to higher hiv, oncology and liver disease sales. Gilead sciences (gild 0.80%) q1 2024 earnings call apr 25, 2024, 4:30 p.m.
Check Out Whether Gild Stock Is A Good Buy Ahead Of Q1 Earnings.
My name is rebecca, and i'll be your host for today.
First Quarter 2024 Financial Results.
Total first quarter 2024 revenue increased 5% to $6.7 billion, compared to the same period in 2023, primarily due to higher hiv, oncology and liver disease sales.
During The First Quarter 2024, Gilead Generated $2.2 Billion In Operating Cash Flow.
Images References :
Gilead Sciences (Gild) Came Out With A Quarterly Loss Of $1.32 Per Share Versus The Zacks Consensus Estimate Of A Loss Of $1.49.
I can share that we are tentatively planning to release our second quarter 2024 earnings results on thursday, august 8.
My Name Is Rebecca, And I'll Be Your Host For Today.
Gilead sciences will report its q1 2024 earnings on thursday, april 25.
Gild) Q1 2024 Earnings Call Transcript April 25, 2024.